Found 6 matching trials
A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine
PHASE1This clinical drug-drug interaction study is being conducted to evaluate th...
Location
Multiple Locations
Abraxane and Temodar Plus Genasense in Advanced Melanoma
PHASE1This study is designed to evaluate the safety, efficacy, pharmacokinetics, ...
Location
New York University Cancer Center
Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
NARATIONALE: Drugs used in chemotherapy, such as dacarbazine, use different w...
Location
Jonsson Comprehensive Cancer Center, UCLA
Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma
PHASE3RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
Jonsson Comprehensive Cancer Center, UCLA
Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
PHASE3This study is being performed to prospectively determine whether dacarbazin...
Location
University of South Alabama Hospital, Mitchell Cancer Institute
Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment
PHASE2This is an open-label, parallel-group study with a total of 16 evaluable su...
Location
Multiple Locations